The phototherapy toward corneal neovascularization elimination: An efficient, selective and safe strategy

Jingwen Yu, Chengchao Chu, Yiming Wu, Gang Liu*, Wei Li*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Abstract

Corneal neovascularization (CNV) can induce severe visual impairment and even blindness. Current treatments have limited efficacy and some undesirable side effects. Phototherapy (PT) is a modern medical technique in CNV treatment and worth further improvement. Nanotechnology has various advantages and nanoparticle-mediated drug delivery also contributes to CNV elimination. Phototherapy combined with functional nanoparticles featuring photoacoustic imaging contrast properties can accomplish accurate and safe inhibition of CNV, thus is promising in clinical application.
Original languageEnglish
Pages (from-to)99-101
Number of pages3
JournalChinese Chemical Letters
Volume32
Issue number1
Early online date20 Nov 2020
DOIs
Publication statusPublished - Jan 2021

Bibliographical note

Acknowledgments:
This study was supported in part by the National Key R&D Program of China (Nos. 2018YFA0107301 and 2018YFA0107304), the National Natural Science Foundation of China (NSFC, Nos. 81770894, 81901876, 81470602 and 81330022) and the Fundamental Research Funds for the Central Universities (Nos. 20720190088 and 20720200019), the Medical and Health Key Project of Xiamen (No. 3502Z20191106), and the Program for New Century Excellent Talents in University, China (No. NCET-13-0502).

Keywords

  • Corneal neovascularization
  • Phototherapy
  • Nanotechnology
  • R-nanoICG
  • Photoacoustic imaging

Fingerprint

Dive into the research topics of 'The phototherapy toward corneal neovascularization elimination: An efficient, selective and safe strategy'. Together they form a unique fingerprint.

Cite this